Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Notice of Participation of the Food and Drug Administration in PAR-22-167, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) ✔ NOT-TR-24-005 11/02/2023 Notice of Information
Notice of Special Interest (NOSI): Collaborative and Innovative Research to Advance Regulatory Science: Partnership of FDA Centers of Excellence in Regulatory Science and Innovation (CERSI) and NIH Clinical and Translational Science Award (CTSA) Programs ✔ NOT-TR-24-006 UG3/UH3 11/02/2023 10/17/2024 Notice of Special Interest
Notice of Termination of PAR-21-340 "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trial Not Allowed) ✔ NOT-TR-24-001 11/08/2023 Notice of Change to Funding Opportunity
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional) ✔ PAR-24-054 RC2 11/07/2023 09/14/2026 NA
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) ✘ PAR-24-046 R21 10/20/2023 11/19/2024 NA
Notice of Termination of PAR-22-100 "Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) ✔ NOT-TR-23-008 04/13/2023 Notice of Change to Funding Opportunity
Notice of Change in Eligibility to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
 		✔ NOT-TR-22-024 03/23/2022 Notice of Change to Funding Opportunity
Notice of Change in Funding Opportunity Description and Application and Submission Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional)
✔ NOT-TR-22-026 03/21/2022 Notice of Change to Funding Opportunity
Notice of Intent to Publish a Funding Opportunity Announcement for Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) ✔ NOT-TR-22-016 03/02/2022 Notice of Intent to Publish
Notice of Change in Award Information to PAR-21-293 Clinical and Translational Science Award (UM1 Clinical Trial Optional) ✔ NOT-TR-22-025 03/21/2022 Notice of Change to Funding Opportunity
Showing Row 101 to 110 of 419

Last updated on February 19, 2025